Ovid Therapeutics
Price & Volume
Stats
See more52W Range | $1.18-$3.10 |
Market Cap | $480.4M |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | -88.3% |
Gross Profit (12 Mos) | $1.5M |
Diluted EPS | -$0.22 |
News
See moreYahoo Finance • last month
Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two
Yahoo Finance • last month
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • 3 months ago
Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer
About
CEO | Ms. Margaret Alexander |
CFO | Mr. Charles Ross Carter M.B.A., M.S. |
Address | Hudson Commons, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |